All 132 BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Holdings
There are 132 BBC holdings. Top 10 companies weight: 10.66%.
Total Market Cap: $312B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (132 stocks) | +12.97% | 8.31 | 4.33 | 0.25 | +62.28% | +9.24% | 1.24 | ||||||||||
1 | TRAX | First Tracks Biotherapeutics Inc | 1.29% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | DFTX | N/A | 1.16% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | RGNX | Regenxbio Inc | 1.16% | $10.32 | $633M | Biotechnology | Healthcare | +13.05% | N/A | N/A | N/A | N/A | N/A | 81 | +135.17% | $24 | -22.82% | 1.83 |
4 | MNPR | Monopar Therapeutics Inc | 1.15% | $105.90 | $728M | Biotechnology | Healthcare | -5.81% | N/A | N/A | N/A | N/A | N/A | 82 | +7.29% | $114 | +31.10% | 1.67 |
5 | MBX | Mbx Biosciences Inc | 1.08% | $60.14 | $2.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +14.73% | $69 | 0.00% | 1.44 |
6 | SLS | Sellas Life Sciences Group Inc | 1.03% | $12.48 | $2.32B | Biotechnology | Healthcare | -32.56% | N/A | N/A | N/A | N/A | N/A | 87 | +120.44% | $28 | +6.05% | 0.90 |
7 | APGE | Apogee Therapeutics Inc | 0.96% | $134.15 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | -2.70% | $131 | 0.00% | 1.25 |
8 | ERAS | Erasca Inc | 0.95% | $18.82 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +21.15% | $23 | -1.13% | 1.37 |
9 | DMRA | Damora Therapeutics Inc Ordinary Shares | 0.94% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | QURE | Uniqure Nv | 0.94% | $39.70 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +63.40% | $65 | +7.92% | 0.98 |
11 | ZBIO | Zenas Biopharma Inc | 0.94% | $30.70 | $1.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +37.20% | $42 | 0.00% | 1.24 |
12 | JBIO | Jade Biosciences Inc | 0.90% | $19.67 | $1.08B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +146.57% | $49 | -45.27% | 0.53 |
13 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.89% | $22.71 | $2.47B | Biotechnology | Healthcare | +10.31% | N/A | N/A | N/A | N/A | N/A | 81 | +43.11% | $33 | -5.48% | 1.36 |
14 | PVLA | Palvella Therapeutics Inc | 0.88% | $124.15 | $2.18B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +84.94% | $230 | 0.00% | 1.01 |
15 | ANNX | Annexon Inc Ordinary Shares | 0.87% | $5.57 | $1.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +167.15% | $15 | -24.53% | 1.23 |
16 | ATAI | Ataibeckley Inc | 0.86% | $7.19 | $1.96B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +75.10% | $13 | -15.80% | 1.41 |
17 | MPLT | Maplight Therapeutics Inc | 0.85% | $35.99 | $1.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +15.31% | $42 | 0.00% | 1.36 |
18 | NGNE | Neurogene Inc | 0.85% | $37.34 | $616M | Biotechnology | Healthcare | +11.24% | N/A | N/A | N/A | N/A | N/A | 75 | +118.83% | $82 | -26.10% | 1.88 |
19 | ORIC | Oric Pharmaceuticals Inc | 0.85% | $10.42 | $1.15B | Biotechnology | Healthcare | -10.25% | N/A | N/A | N/A | N/A | N/A | 76 | +94.72% | $20 | -10.75% | 1.45 |
20 | SLDB | Solid Biosciences Inc | 0.85% | $8.45 | $947M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +107.10% | $18 | -28.67% | 1.77 |
21 | RCKT | Rocket Pharmaceuticals Inc | 0.84% | $3.43 | $398M | Biotechnology | Healthcare | -5.96% | N/A | N/A | N/A | N/A | N/A | 53 | +173.76% | $9.39 | -40.75% | 1.35 |
22 | BHVN | Biohaven Ltd | 0.83% | $14.84 | $2.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +53.30% | $23 | 0.00% | 1.45 |
23 | SANA | Sana Biotechnology Inc Ordinary Shares | 0.83% | $3.14 | $958M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +172.93% | $8.57 | -30.37% | 1.98 |
24 | FDMT | N/A | 0.83% | $11.09 | $611M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +154.46% | $28 | -14.78% | 1.22 |
25 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.83% | $23.45 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +67.16% | $39 | +3.77% | 1.77 |
26 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.83% | $111.06 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +12.68% | $125 | +14.19% | 1.52 |
27 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.83% | $19.18 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +32.33% | $25 | -11.08% | 1.84 |
28 | MGTX | Meiragtx Holdings Plc | 0.83% | $12.21 | $1.02B | Biotechnology | Healthcare | -1.60% | N/A | 1.62 | N/A | N/A | N/A | 81 | +132.43% | $28 | -3.84% | 1.29 |
29 | VKTX | Viking Therapeutics Inc | 0.83% | $36.38 | $4.38B | Biotechnology | Healthcare | +47.58% | N/A | N/A | N/A | N/A | N/A | 78 | +154.48% | $93 | +43.88% | 1.52 |
30 | ANRO | Alto Neuroscience Inc | 0.82% | $25.97 | $973M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +35.27% | $35 | 0.00% | 1.26 |
31 | BCAX | Bicara Therapeutics Inc | 0.82% | $27.15 | $1.84B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +15.87% | $31 | 0.00% | 1.40 |
32 | XENE | Xenon Pharmaceuticals Inc | 0.82% | $66.04 | $6.54B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +21.99% | $81 | +29.09% | 0.92 |
33 | CGEM | Cullinan Therapeutics Inc | 0.82% | $17.50 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +80.29% | $32 | -8.28% | 1.05 |
34 | GLUE | Monte Rosa Therapeutics Inc | 0.81% | $23.48 | $1.97B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +41.27% | $33 | +1.58% | 1.31 |
35 | ABCL | Abcellera Biologics Inc Ordinary Shares | 0.81% | $5.80 | $2.05B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +81.03% | $11 | -18.99% | 1.66 |
36 | MANE | Veradermics Inc | 0.81% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
37 | GHRS | Gh Research Plc | 0.80% | $27.53 | $1.67B | Biotechnology | Healthcare | +89.13% | N/A | N/A | N/A | N/A | N/A | 83 | +43.48% | $40 | +9.62% | 0.92 |
38 | IDYA | Ideaya Biosciences Inc | 0.80% | $35.45 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +47.50% | $52 | +10.45% | 1.10 |
39 | SYRE | Spyre Therapeutics Inc | 0.80% | $97.33 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +6.78% | $104 | -10.71% | 1.74 |
40 | PRME | Prime Medicine Inc | 0.79% | $3.05 | $630M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +133.44% | $7.12 | 0.00% | 2.09 |
41 | VOR | Vor Biopharma Inc Ordinary Shares | 0.79% | $17.45 | $980M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +117.08% | $38 | -43.35% | 1.23 |
42 | IMMX | Immix Biopharma Inc | 0.79% | $8.80 | $558M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 87 | +124.43% | $20 | 0.00% | 1.23 |
43 | IMNM | Immunome Inc Ordinary Shares | 0.79% | $22.16 | $2.59B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +61.42% | $36 | +4.86% | 1.64 |
44 | AVTX | Avalo Therapeutics Inc | 0.79% | $18.21 | $404M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +145.41% | $45 | -70.96% | 0.53 |
45 | CRVS | Corvus Pharmaceuticals Inc | 0.79% | $14.10 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +136.38% | $33 | +43.22% | 0.75 |
46 | BIOA | Bioage Labs Inc | 0.79% | $22.32 | $1.01B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +121.77% | $50 | 0.00% | 1.04 |
47 | DSGN | Design Therapeutics Inc | 0.78% | $11.87 | $844M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 82 | +76.92% | $21 | -8.04% | 1.13 |
48 | SION | Sionna Therapeutics Inc | 0.78% | $45.69 | $2B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 68 | +12.93% | $52 | 0.00% | 0.90 |
49 | KOD | Kodiak Sciences Inc | 0.78% | $40.87 | $2.64B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 78 | +53.34% | $63 | -14.24% | 1.68 |
50 | VERA | Vera Therapeutics Inc Class A | 0.78% | $36.99 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +121.11% | $82 | +17.52% | 1.22 |
BBC (VIRTUS BIOTECH CLINICAL TRIALS ETF) Sector Allocation
HEALTHCARE
90.20%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%